Storia in 2 fonti

Scientists discover a nighttime benefit of weight loss jabs

A review has found that up to half of patients using tirzepatide - the active ingredient in the blockbuster jab Mounjaro - banished their sleep apnoea.

Raccontata da

independent.co.uk

dailymail.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

dailymail.comStai leggendo7 g fa

Scientists discover a nighttime benefit of weight loss jabs

A review has found that up to half of patients using tirzepatide - the active ingredient in the blockbuster jab Mounjaro - banished their sleep apnoea.

originale

independent.co.uk9 g fa

Experimental weight loss jab outperforms Mounjaro in latest study

Retatrutide could help people lose almost 25 per cent of their body weight

Leggi questa versione → originale

Timeline cronologica

martedì 1 settembre 2026·independent.co.uk
Experimental weight loss jab outperforms Mounjaro in latest study
Retatrutide could help people lose almost 25 per cent of their body weight
giovedì 3 settembre 2026·dailymail.com
Scientists discover a nighttime benefit of weight loss jabs
A review has found that up to half of patients using tirzepatide - the active ingredient in the blockbuster jab Mounjaro - banished their sleep apnoea.